Day One Biopharmaceuticals, Inc. DAWN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

51/100

2/7 Pass

SharesGrow Intrinsic Value

Day One Biopharmaceuticals, Inc. (DAWN) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Blavatnik Len 10,684,638 주 보유. 기타 주요 보유자에는 Canaan XI L.P. 및 TAKEDA PHARMACEUTICAL CO LTD.

지난 12개월간 내부자는 43 건의 거래를 수행 DAWN 주식 — 14 건 매수 (평가액 RSU 보상) 및 13 건 매도 (평가액 $839.84K). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

DAWN 내부자 보유 현황

최대 보유자

Blavatnik Len

10,684,638 주

매수 (12개월)

$0.00 평가액

매도 (12개월)

$839.84K 평가액

12개월 거래 활동

매수 33%

매도 30%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Blavatnik Len	Director	10,684,638	2022-06-21	100%
2	Canaan Xi L.p.	10 Percent Owner	6,964,301	2022-09-22	65%
3	Takeda Pharmaceutical Co Ltd	10 Percent Owner	6,230,462	2021-12-09	58%
4	Atlas Venture Fund Xi, L.p.	Director	6,008,534	2022-12-14	56%
5	Blackman Samuel C.	Head of R&d	1,034,015	2024-12-12	10%
6	Ai Day1 Llc	10 Percent Owner	827,586	2024-08-05	8%
7	Atlas Venture Opportunity Fund I, L.p.	Director	793,116	2022-07-06	7%
8	Atlas Venture Opportunity Fund Ii, L.p.	10 Percent Owner	766,667	2022-06-22	7%
9	Atlas Venture Associates Opportunity I, Llc	Director	766,667	2022-06-22	7%
10	Grant Papanek Julie	Director	439,358	2022-09-15	4%
11	Grant Julie Papanek	Director	330,000	2023-03-03	3%
12	Becker Daniel J.	Director	37,500	2023-06-26	0%
13	Gladstone Michael	Director	32,335	2024-05-28	0%
14	Merendino Lauren	Chief Commercial Officer	18,978	2026-02-18	0%
15	Grossman William	Director	15,000	2025-06-04	0%
16	Ramasastry Saira	Director	15,000	2025-06-04	0%
17	Josey John A.	Director	15,000	2025-06-04	0%
18	Dable Habib J	Director	15,000	2025-06-04	0%
19	Nicholson Garry A	Director	15,000	2025-06-04	0%
20	Garland J. Scott	Director	15,000	2025-06-04	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-02-17	Bender Jeremy	Chief Executive Officer	정보 매도	15,459	$11.60	$179.34K
2026-02-15	Bender Jeremy	Chief Executive Officer	옵션 행사 (매도)	4,750	-	-
2026-02-17	Merendino Lauren	Chief Commercial Officer	정보 매도	5,814	$11.60	$67.45K
2026-02-15	Merendino Lauren	Chief Commercial Officer	옵션 행사 (매도)	3,162	-	-
2026-02-17	Dubow Adam	Gen Counsel & Secretary	정보 매도	6,395	$11.60	$74.19K
2026-02-15	Dubow Adam	Gen Counsel & Secretary	옵션 행사 (매도)	1,750	-	-
2026-02-17	Vasconcelles Michael	Head of Research and Dev.	정보 매도	2,728	$11.60	$31.65K
2026-02-15	Vasconcelles Michael	Head of Research and Dev.	옵션 행사	7,125	-	-
2026-02-17	York Charles N Ii	COO and CFO	정보 매도	6,065	$11.60	$70.36K
2026-02-15	York Charles N Ii	COO and CFO	옵션 행사 (매도)	2,250	-	-
2026-01-30	Bender Jeremy	Chief Executive Officer	RSU 부여	237,000	-	-
2026-01-30	Merendino Lauren	Chief Commercial Officer	RSU 부여	74,000	-	-
2026-01-30	Dubow Adam	Gen Counsel & Secretary	RSU 부여	70,000	-	-
2026-01-30	Vasconcelles Michael	Head of Research and Dev.	RSU 부여	114,000	-	-
2026-01-30	York Charles N Ii	COO and CFO	RSU 부여	126,000	-	-
2025-11-25	Bender Jeremy	Chief Executive Officer	증여 (지급)	7,225	-	-
2025-11-17	Bender Jeremy	Chief Executive Officer	정보 매도	15,894	$8.91	$141.69K
2025-11-15	Bender Jeremy	Chief Executive Officer	옵션 행사 (매도)	3,570	-	-
2025-11-17	Merendino Lauren	Chief Commercial Officer	정보 매도	3,726	$8.91	$33.22K
2025-11-15	Merendino Lauren	Chief Commercial Officer	옵션 행사 (매도)	3,162	-	-
2025-11-17	Dubow Adam	Gen Counsel & Secretary	정보 매도	4,319	$8.91	$38.5K
2025-11-15	Dubow Adam	Gen Counsel & Secretary	옵션 행사 (매도)	1,750	-	-
2025-11-17	York Charles N Ii	COO and CFO	정보 매도	4,062	$8.91	$36.21K
2025-11-15	York Charles N Ii	COO and CFO	옵션 행사 (매도)	1,375	-	-
2025-11-06	Bender Jeremy	Chief Executive Officer	주식 반환	286,000	$11.87	$3.39M